Lung Cancer Episode 10: ADAURA presents OS data on adjuvant osermitinib in EFGR-mutated NSCLC patients 23 April 2024
GUUrothelial cancer Episode 12: Erdafitinib versus chemotherapy and pembrolizumab in FGFRalt metastatic urothelial carcinoma 22 April 2024
Breast Cancer Episode 22: Neoadjuvant and adjuvant pembrolizumab in early-stage high-risk ER+/HER2- breast cancer: KEYNOTE-756 18 April 2024
Lung Cancer Episode 9: Continuous treatment with immunotherapy does not improve OS in metastatic NSCLC patients 16 April 2024
GURenal cancer Episode 11: The efficacy of belzutifan on PFS and ORR in metastatic ccRCC: Litespark-005 15 April 2024
Breast Cancer Episode 21: Neoadjuvant immunotherapy for high-risk ER+/HER2- breast cancer: insights from the CheckMate-7FL trial 28 March 2024
GI Episode 12: The RATIONALE-306 study solidifies checkpoint inhibition therapy in ESCC 27 March 2024
GUUrothelial cancer Episode 10: Enhancing neoadjuvant chemotherapy with immune checkpoint inhibition in MIBC: insights from the NEMIO Trial 25 March 2024
Breast Cancer Episode 20: Primary results from the TROPION-Breast01 study on Dato-DXd in HR+/HER2- metastatic breast cancer treatment 21 March 2024
GI Episode 11: Sotorasib plus panitumumab increases PFS in metastatic KRAS G12C mutated colorectal cancer patients: CodeBreak 300 20 March 2024
